Clinical,pathological and Genetic Features of Lipid Storage Myopathy Presenting As Rhabdomyolysis

姜涛,熊李,漆学良,丁卫江
DOI: https://doi.org/10.19845/j.cnki.zfysjjbzz.2016.01.014
2016-01-01
Abstract:Objective Some cases of lipid storage myopathy( LSM) are present as rhabdomyolysis. To study the clinical,pathological and genetic features is helpful to diagnosis the LSM presenting as rhabdomyolysis. Methods Three cases of LSM presenting as acute rhabdomyolysis were analyzed on clinical,pathological and genetic features. The related literatures were reviewed. Results Two cases were present as rhabdomyolysis firstly. In one case who had been diagnosed as LSM,rhabdomyolysis was induced by the upper respiratory tract infection after drug withdrawal. Electrophysiology showed myogenic damage in one case,while the others were normal. All of the muscle specimens showed typical accumulation of lipid in muscle fibers. Necrotic fibers were found in 2 cases. Two patients performed ETFA、ETFB、ETFDH genetic testing. ETFA genetic testing was normal,while both the ETFB gene analysis identified a c. 734 C > T( Thr245Met) heterozygous mutation and ETFDH gene analysis identified a c. 92 C > T( Thr3Ile) heterozygous mutation. Conclusion When patients occur as muscle pain and fatigue accompany with high level of CK in serum and myoglobinuria repeatedly,LSM should be considered. Muscle biopsies and histochemical studies are necessary to diagnosis LSM. Clinical significance of two heterozygous mutation of the gene is unknown. Two heterozygous mutations may be polymorphic loci. Stop taking the drugs and have a cold may be the risk factors for LSM patients to have acute rhabdomyolysis.
What problem does this paper attempt to address?